Chemoprevention of azoxymethane-induced rat colon carcinogenesis by a xanthine oxidase inhibitor, 1'-acetoxychavicol acetate

Japanese Journal of Cancer Research

Volumn 88, Issue 9, 1997, Pages 821-830

  Tanaka, Takuji ^a,e   Kawabata, Kunihiro ^a   Kakumoto, Mikio ^a   Makita, Hiroki ^b   Matsunaga, Kengo ^a   Mori, Hideki ^a   Satoh, Kumiko ^a   Hara, Akira ^a   Murakami, Akira ^c   Koshimizu, Koichi ^c   Ohigashi, Hajime ^d  

^a GIFU UNIVERSITY   (Japan)

^b GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^c KINKI UNIVERSITY   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

1' Acetoxychavicol acetate; Azoxymethane; Chemoprevention; Colon tumorigenesis; Rats

Indexed keywords

AZOXYMETHANE; GLUTATHIONE TRANSFERASE; ORNITHINE DECARBOXYLASE; POLYAMINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); XANTHINE OXIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; CELL PROLIFERATION; CHEMOPROPHYLAXIS; COLON ADENOCARCINOMA; COLON CARCINOGENESIS; COLON CARCINOMA; COLON MUCOSA; CONTROLLED STUDY; ENZYME ACTIVITY; INTESTINE CELL; INTESTINE CRYPT; MALE; MUCOSA CELL; NONHUMAN; ORAL DRUG ADMINISTRATION; PLANT; PRIORITY JOURNAL; RAT; THAILAND;

EID: 0030707741     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1997.tb00457.x     Document Type: Article

References (62)

1. Shike, M., Winawer, S. J., Greenwald, P. H., Bloch, A., Hill, M. J. and Swaroop, S. V. Primary prevention of colorectal cancer: the WHO Collaborating Centre for Prevention of Colorectal Cancer. Bull. World Health Organ., 68, 377-385 (1990).
2. Weisburger, J. H. Nutritional approach to cancer prevention with emphasis on vitamins, antioxidants, and carotenoids. Am. J. Clin. Nutr., 53, 226S-237S (1991).
3. Dove, W. F., Gould, K. A., Luongo, C., Moser, A. R. and Shoemaker, A. R. Emergent issues in the genetics of intestinal neoplasia. Cancer Surv., 25, 335-355 (1995).
4. Tanaka, T. Effect of diet on human carcinogenesis. Crit. Rev. Oncol./Hematol., 25, 73-95 (1997).
5. Haenszel, W., Licks, F. B. and Segi, M. A case-control study of large bowel cancer in Japan. J. Natl. Cancer Inst., 64, 17-22 (1980).
6. Broder, S. Perspectives on cancer in Japan and the United States. Jpn. J. Cancer Res., 84, 821-830 (1993).
7. Block, G., Patterson, B. and Subar, A. Fruit, vegetables, and cancer prevention: a review of epidemiological evidence. Nutr. Cancer, 18, 1-29 (1992).
8. Tanaka, T. Chemoprevention of human cancer: biology and therapy. Crit. Rev. Oncol./Hematol., 25, 139-174 (1997).
9. Cerutti, P. A. Oxy-radicals and cancer. Lancet, 344, 862-863 (1994).
10. Cerutti, P. A. Oxidant stress and carcinogenesis. Eur. J. Clin. Invest., 21, 1-5 (1991).
11. Qureshi, A., Gorey, T. F., Byrne, P., Kay, E., McKeever, J. and Hennessy, T. P. J. Oxygen free radical activity in experimental colonic carcinoma. Br. J. Surg., 81, 1058-1059 (1994).
12. Parks, D. A. and Granger, D. N. Xanthine oxidase: biochemistry, distribution and physiology. Acta Physiol. Scand., 548 (Suppl.), 87-99 (1986).
13. McCord, J. M. and Fridovich, I. The reduction of cytochrome C by milk xanthine oxidase. J. Biol. Chem., 243, 5753-5760 (1968).
14. Kokoglu, E., Belce, A., Ozyurt, E. and Tepeler, Z. Xanthine oxidase levels in human brain tumors. Cancer Lett., 50, 179-181 (1990).
15. Reiners, J. J., Jr., Thai, G., Rupp, T. and Cantu, A. R. Assessment of the antioxidant/prooxidant status of murine skin following topical treatment with 12-O-tetradecanoyl-phorbol-13-acetate and throughout the ontogeny of skin cancer. Part I. Quantitation of superoxide dismutase, catalase, glutathione peroxidase and xanthine oxidase. Carcinogenesis, 12, 2337-2343 (1991).
16. Pence, B. C. and Reiners, J. J., Jr. Murine epidermal xanthine oxidase activity: correlation with degree of hyperplasia induced by tumor promoters. Cancer Res., 47, 6388-6392 (1987).
17. Tanaka, T. Cancer chemoprevention by natural products (Review). Oncol. Rep., 1, 1139-1155 (1994).
18. Wei, H., Bowen, R., Cai, Q., Barnes, S. and Wang, Y. Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc. Soc. Exp. Biol. Med., 208, 124-130 (1995).
19. Klaunig, J. E. Chemopreventive effects of green tea components on hepatic carcinogenesis. Prev. Med., 21, 510-519 (1992).
20. Mitsui, S., Kobayashi, S., Nagahori, H. and Ogiso, A. Constituents from seeds of Alpinia galanga wild, and their anti-ulcer activities. Chem. Pharm. Bull., 24, 2377-2382 (1976).
21. Noro, T., Sekiya, T., Katoh, M., Oda, Y., Miyase, T., Kuroyanagi, M., Ueno, A. and Fukushima, S. Inhibitors of xanthine oxidase from Alpinia galanga. Chem. Pharm. Bull., 36, 244-248 (1988).
22. Kondo, A., Ohigashi, H., Murakami, A., Suratwadee, J. and Koshimizu, K. 1′-Acetoxychavicol acetate as a potent inhibitor of tumor promoter-induced Epstein-Barr virus activation from Languas galanga, a traditional Thai condiment. Biosci. Biotech. Biochem., 57, 1344-1345 (1993).
23. Ohnishi, M., Tanaka, T., Makita, H., Kawamori, T., Mori, H., Satoh, K., Hara, A., Murakami, A., Ohigashi, H. and Koshimizu, K. Chemopreventive effect of a xanthine oxidase inhibitor, 1′-acetoxychavicol acetate, on rat oral carcinogenesis. Jpn. J. Cancer Res., 87, 349-356 (1996).
24. Bird, R. P. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett., 93, 55-71 (1995).
25. Pretlow, T. P., Barrow, B. J., Ashton, W. S., O'Riordan, M. A., Pretlow, T. G., Jurcisek, J. A. and Stellato, T. A. Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res., 51, 1564-1567 (1991).
26. McLellan, E. A., Medline, A. and Bird, R. P. Sequential analysis of the growth and morphological characteristics of aberrant crypt foci: putative preneoplastic lesions. Cancer Res., 51, 5270-5274 (1991).
27. Pereira, M. A., Barnes, L. H., Rassman, V. L., Kelloff, G. V. and Steele, V. E. Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents. Carcinogenesis, 15, 1049-1054 (1994).
28. Tanaka, T. and Mori, H. Inhibition of colon carcinogenesis by non-nutritive constituents in foods. J. Toxicol. Pathol., 9, 139-149 (1996).
29. Mori, H., Tanaka, T., Sugie, S. and Yoshimi, N. Chemopreventive effects of plant derived phenolic, organosulfur and other compounds on carcinogenesis in digestive organs. Environ. Mutagen. Res. Commun., 17, 127-133 (1995).
30. Tanaka, T., Kojima, T., Kawamori, T. and Mori, H. Chemoprevention of digestive organs carcinogenesis by natural product protocatechuic acid. Cancer, 75 (Suppl.), 1433-1439 (1995).
31. Carter, J. W., Lancaster, H. K., Hardman, W. E. and Cameron, I. L. Distribution of intestine-associated lymphoid tissue, aberrant crypt foci, and tumors in the large bowel of 1,2-dimethylhydrazine-treated mice. Cancer Res., 54, 4304-4307 (1994).
32. Kristiansen, E. The role of aberrant crypt foci induced by the two heterocyclic amines 2-amino-3-methylimidazo-[4,5-f]quinoline (IQ) and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the development of colon cancer in mice. Cancer Lett., 110, 187-192 (1996).
33. Pretlow, T. P., O'Riordan, M. A., Somich, G. A., Amini, S. B. and Pretlow, T. G. Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate. Carcinogenesis, 13, 1509-1512 (1992).
34. Zhang, X.-M., Stamp, D., Minkin, S., Medline, A., Corpet, D. E., Bruce, W. R. and Archer, M. C. Promotion of aberrant crypt foci and cancer in rat colon by thermolyzed protein. J. Natl. Cancer Inst., 84, 1026-1030 (1992).
35. Magnuson, B. A., Carr, I. and Bird, R. P. Ability of aberrant crypt foci characteristics to predict colonic tumor incidence in rats fed cholic acid. Cancer Res., 53, 4499-4504 (1993).
36. Tanaka, T., Makita, H., Kawamori, T., Kawabata, K., Mori, H., Murakami, A., Satoh, K., Hara, A., Ohigashi, H. and Koshimizu, K. A xanthine oxidase inhibitor 1′-acetoxychavicol acetate inhibits azoxymethane-induced colonic aberrant crypt foci in rats. Carcinogenesis, 18, 1113-1118 (1997).
37. Einspahr, J. G., Alberts, D. S., Gapstur, S. M., Bostick, R. M., Emerson, S. S. and Gerner, E. W. Surrogate endpoint biomarkers as measures of colon cancer risk and their use in cancer chemoprevention trials. Cancer Epidemiol. Biomarkers Prev., 6, 37-48 (1997).
38. Talalay, P. Chemical protection against cancer by induction of electrophile detoxification (Phase II) enzymes. In "Cellular and Molecular Targets for Chemoprevention," ed. V. E. Steele, G. D. Stoner, C. W. Boone and G. J. Kelloff, pp. 193-205 (1992). CRC Press, Boca Raton, FL.
39. Prochaska, H. J. and Talalay, P. The role of NAD(P)-H:quinone reductase in protection against the toxicity of quinones and related agents. In "Oxidative Stress: Oxidants and Antioxidants," ed. H. Sies, pp. 195-211 (1991). Academic Press, London.
40. Ward, J. M. Morphogenesis of chemically induced neoplasms of the colon and small intestine in rats. Lab. Invest., 30, 505-513 (1974).
41. Hard, C. C. and Butler, W. H. Cellular analysis of renal neoplasia: induction of renal tumors in dietary-conditioned rats by dimethylnitrosamine with a reappraisal of morphological characteristics. Cancer Res., 30, 2796-2805 (1970).
42. Koide, T. The clinical significance of tissue, blood and urine polyamine in renal cell carcinoma. Jpn. J. Urol., 83, 1228-1237 (1992) (in Japanese).
43. Koide, T., Sakai, S., Takeda, A., Doi, T., Tei, K., Hara, A. and Sawada, H. Detection of polyamines by a new enzymatic differential assay. (4) Fundamental study on a new enzymatic differential assay of blood. Acta Urol. Jpn., 32, 913-917 (1986) (in Japanese).
44. Benson, A. M., Batzinger, R. P., Ou, S.-Y. L., Bueding, E., Cha, Y.-N. and Talalay, P. Elevation of hepatic glutathione S-transferase activities and protection against metabolites of benzo[a]pyrene by dietary antioxidants. Cancer Res., 38, 4486-4495 (1978).
45. De Long, M. J., Prochaska, H. J. and Talalay, P. Tissue-specific induction patterns of cancer-protective enzymes in mice by tert-butyl-4-hydroxyanisole and related substituted phenols. Cancer Res., 45, 546-551 (1985).
46. Prochaska, H. and Fernandes, C. L. Elevation of serum Phase II enzymes by anticarcinogenic enzyme inducers: markers for a chemoprotected state? Carcinogenesis, 14, 2441-2445 (1993).
47. Benson, A. M., Hunkeler, M. J. and Talalay, P. Increase of NAD(P)H:quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity. Proc. Natl. Acad. Sci. USA, 77, 5216-5220 (1980).
48. Habig, W. H., Pabst, M. J. and Jakoby, W. B. Glutathione S-transferases. J. Biol. Chem., 249, 7130-7139 (1974).
49. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254 (1976).
50. Wattenberg, L. W. Inhibition of carcinogenesis by minor anutrient constituents of the diet. Proc. Nutr. Soc., 49, 173-183 (1990).
51. Hoffman, C. E. J., Webster, N. R., Wiggins, P. A., Chisholm, E. M., Giles, G. R. and Leveson, S. H. Free radical detoxifying systems in human colorectal cancer. Br. J. Cancer, 51, 127-129 (1985).
52. Guyton, K. Z. and Kensler, T. W. Oxidative mechanisms in carcinogenesis. Br. Med. Bull., 49, 523-544 (1993).
53. Oravec, C. T., Jones, C. A. and Huberman, E. Activation of the colon carcinogen 1,2-dimethylhydrazine in a rat colon cell-mediated mutagenesis assay. Cancer Res., 46, 5068-5071 (1986).
54. Fiala, E. S. Investigations into the metabolism and mode of action of the colon carcinogens 1,2-dimethylhydrazine and azoxymethane. Cancer, 40 (Suppl. 5), 2436-2445 (1977).
55. Fiala, E. S., Kulakis, C., Christiansen, G. and Weisburger, J. H. Inhibition of the metabolism of the colon carcinogen, azoxymethane, by pyrazole. Cancer Res., 38, 4515-4521 (1978).
56. Fiala, E. S., Caswell, N., Sohn, O. S., Felder, M. R., McCoy, G. D. and Weisburger, J. H. Non-alcohol dehydrogenase-mediated metabolism of methylazoxymethanol in the deer mouse, Peromyscus maniculatus. Cancer Res., 44, 2885-2891 (1984).
57. Zedeck, M. S., Frank, N. and Wiessler, M. Metabolism of the colon carcinogen methylazoxymethanol acetate. Front. Gastrointest. Res., 4, 32-37 (1979).
58. Fiala, E. S., Bobotas, G., Kulakis, C., Wattenberg, L. W. and Weisburger, J. H. Effects of disulfiram and related compounds on the metabolism in vivo of the colon carcinogen, 1,2-dimethylhydrazine. Biochem. Pharmacol., 26, 1763-1768 (1977).
59. Wattenberg, L. W., Lam, L. K. T., Fladmoe, A. and Borchert, P. Inhibitors of colon carcinogenesis. Cancer, 40, 2435-2445 (1977).
60. Fiala, E. S. Inhibition of carcinogen metabolism and action by disulfiram, pyrazole, and related compounds. In "Inhibition of Tumor Induction and Development," ed. M. S. Zedeck and M. Lipkin, pp. 23-69 (1981). Plenum Publ., New York.
61. Cohen, S. M. and Ellwein, L. B. Cell proliferation in carcinogenesis. Science, 249, 1007-1011 (1990).
62. Cantly, L. D., Auger, K. R., Carpenter, C., Duckworth, B., Graziani, A., Kapeller, R. and Soltoff, S. Oncogenes and signal transduction. Cell, 64, 281-302 (1991).